Results 131 to 140 of about 9,904 (152)

Clinical Manifestations, Tumor Associations, and Long-Term Outcomes of Anti-KLHL11 Encephalitis. [PDF]

Neurol Neuroimmunol Neuroinflamm
Jin M, Brand T, Erdag Turgeon E, Havelaar AC, Van Steenhoven RW, Nagtzaam MMP, Franken SC, Abu Hassan SHB, Bastiaansen AEM, Brenner J, Sillevis Smitt PAE, de Graaff E, Veenbergen S, de Vries JM, Kerstens J, Titulaer MJ.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

Annals of Oncology, 2022
M A Climent, Gedske Daugaard, H S Haugnes   +2 more
exaly  

Seminoma subtypes differ in the organization and functional state of the immune microenvironment

3 Biotech, 2023
Kirill E Medvedev
exaly  

Retroperitoneal Seminoma

Ca-A Cancer Journal for Clinicians, 1982
E E Smith
exaly  

Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies

Annals of Oncology, 2011
C Kollmannsberger, S Tyldesley, Siamak Daneshmand   +2 more
exaly  

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

Lancet, The, 2005
H Von Der Maase, G J S Rustin, R De Wit   +2 more
exaly  

Neoadjuvant carboplatin before radiotherapy in stage IIA and IIB seminoma

Annals of Oncology, 2013
D P Dearnaley, R A Huddart, D P Dearnaley   +2 more
exaly  

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

Annals of Oncology, 2014
Jorge Aparicio, P Maroto, A Sanchez-Munoz   +2 more
exaly  

Spermatocytic Seminoma: A Review

European Urology, 2004
Peter Chung, Joan Sweet, Michael A S Jewett   +2 more
exaly